Evaluation of Beta vulgaris total extract effect on improvment of non-alcoholic fatty live disease factors
Phase 2
Recruiting
- Conditions
- on – alcoholic fatty live disease.Other specified inflammatory liver diseases
- Registration Number
- IRCT20121017011145N20
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
?Age 18-70 years old
Non-alcoholic fatty live disease diagnosis
Exclusion Criteria
Pregnancy and lactation
alcohol consumption
Drug addiction
Diabetes mellitus, cirrhosis, hepatitis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method iver aminotransferases. Timepoint: Before starting treatment, three and six months after starting treatment. Method of measurement: ELISA test.;The severity of fatty liver. Timepoint: Before starting treatment, three and six months after starting treatment. Method of measurement: Liver ultrasound.
- Secondary Outcome Measures
Name Time Method Fasting Blood Glucose, Triglycerides, and Cholesterol. Timepoint: Before the intervention, three and six months after the intervention. Method of measurement: Biochemical laboratory tests.